estrogen receptor negative

Related by string. * Estrogen . estrogens . Estrogens : female hormone estrogen . selective estrogen receptor . estrogen metabolism . estrogen receptor / Receptor . receptors . Receptors : estrogen receptor ER . estrogen receptor positive . fewer dopamine receptors / Negatives . negatives . NEGATIVE : Rating Watch Negative . Negative Rating Outlook . Negative Outlook reflects * *

Related by context. Frequent words. (Click for all words.) 76 estrogen receptor positive 70 poorer prognosis 69 HER2 negative 68 hormone receptor positive 66 premenopausal 65 BRCA2 mutations 64 BRCA mutations 63 breast cancers 63 PCa 63 adenoma 62 adenocarcinomas 62 bladder cancers 62 breast tumors 61 neoadjuvant chemotherapy 61 pre menopausal 61 distant metastases 61 HER2 positive 60 colorectal tumors 60 exemestane 60 adjuvant therapy 60 invasive breast cancer 60 adjuvant chemotherapy 60 recurrent ovarian cancer 59 endometrial cancer 59 HER2 + 59 dutasteride 59 prostate cancers 59 postmenopausal breast cancer 59 breast cancer recurrence 59 confidence interval #.#-#.# 58 tamoxifen 58 Adriamycin 58 adenocarcinoma 58 premenopausal women 58 postmenopausal 58 SHBG 58 Metastatic 58 ovarian cancers 58 estrogen receptor 57 adenomas 57 tumor recurrence 57 liver metastases 57 prognostic factor 57 androgen independent 57 mRNA expression 57 rs# [003] 57 Recurrence Score 57 cardiovascular mortality 57 squamous cell 57 PSA velocity 57 ductal carcinoma 57 hepatocellular carcinoma HCC 57 dasatinib 57 colon polyps 56 gefitinib 56 hormonal therapies 56 breast tenderness 56 untreated mice 56 erlotinib 56 DLBCL 56 anastrozole 56 P = .# 56 acute myelogenous leukemia AML 56 neoplasia 56 aromatase 56 neoplasms 56 metastatic renal cell carcinoma 56 hormonal therapy 56 chronic lymphocytic leukemia CLL 56 alpha tocopherol 56 allogeneic stem cell 56 ovarian tumors 56 leukopenia 56 hyperplasia 56 tricyclic antidepressants 55 zoledronic acid 55 ovarian cancer 55 benign lesions 55 CaP 55 EGFR inhibitors 55 estrogen receptors 55 heterozygous 55 CYP#D# 55 trastuzumab 55 isoflavones 55 carcinomas 55 metastatic prostate cancer 55 phytoestrogens 55 fluorouracil 55 nonresponders 55 endocrine therapy 55 nondrinkers 55 HER2 positive breast cancer 55 calcitriol 55 tumors 55 ovarian function 55 lamotrigine 55 HPV# 55 prostate tumor 55 aromatase inhibitor 55 % CI #.#-#.# [006]

Back to home page